Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.8K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.8K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Forced Transdifferentiation01:28

Forced Transdifferentiation

2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.4K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

2.3K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

When vitamins decide life or death.

Cell death and differentiation·2026
Same author

A novel TAp63γ-Airn regulatory axis governs early myogenic gene networks.

Biology direct·2026
Same author

Methodological guidelines for P2X receptor assays and data interpretation.

Cell death & disease·2026
Same author

WWOX maintains epidermal identity and suppresses EMT to prevent aggressive cutaneous squamous cell carcinoma.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Protein lactylation: a metabolic signal driving cancer therapy resistance.

Cell death discovery·2026
Same author

Correction: Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.

Cell death and differentiation·2026
Same journal

Macrophage-secreted brain-derived neurotrophic factor promotes tumor growth in triple-negative breast cancer by inducing axonogenesis.

Cell death and differentiation·2026
Same journal

Species-specific regulation of necroptosis by STK38-dependent RIPK1 phosphorylation.

Cell death and differentiation·2026
Same journal

Ssu72 phosphatase orchestrates obesogenic adipogenesis and metabolic homeostasis during nutrient excess.

Cell death and differentiation·2026
Same journal

SETD7 depletion enhances white adipose browning and ameliorates metabolic disorders in obese mice.

Cell death and differentiation·2026
Same journal

LFPM inhibition of RING1-mediated p53<sup>R175H</sup> degradation drives oncogenesis in p53<sup>R175H</sup>-mutant cancers.

Cell death and differentiation·2026
Same journal

Cell engulfment defines spatially distinct competitive metabolic niches associated with clinical outcomes in colorectal cancer.

Cell death and differentiation·2026
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes
07:25

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes

Published on: July 7, 2022

3.4K

Metabolic reprogramming during neuronal differentiation.

M Agostini1,2, F Romeo1,3, S Inoue4

  • 1Medical Research Council, Toxicology Unit, Leicester University, Leicester LE1 9HN, UK.

Cell Death and Differentiation
|April 9, 2016
PubMed
Summary
This summary is machine-generated.

This study reveals that mitochondrial biogenesis and glucose metabolism significantly increase during early cortical neuron development. These metabolic shifts are crucial for neuronal differentiation, regulated by key signaling pathways.

More Related Videos

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.6K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

757

Related Experiment Videos

Last Updated: Mar 22, 2026

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes
07:25

Isolation and Direct Neuronal Reprogramming of Mouse Astrocytes

Published on: July 7, 2022

3.4K
In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
11:42

In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes

Published on: June 10, 2021

5.6K
Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
09:44

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases

Published on: May 2, 2025

757

Area of Science:

  • Neuroscience
  • Cell Biology
  • Metabolic Research

Background:

  • Newly generated neurons mature through distinct developmental stages for circuit integration.
  • Early cortical neuron development involves migration, axon and dendrite growth, and synapse formation.
  • A comprehensive metabolic analysis during early cortical neuron development was lacking.

Purpose of the Study:

  • To investigate the role of cellular metabolism and mitochondrial biology in ex vivo primary cortical neuron differentiation.
  • To identify key metabolic pathways and regulators involved in neuronal development.

Main Methods:

  • Ex vivo differentiation of primary cortical neurons.
  • Analysis of mitochondrial biogenesis, mass, morphology, and function.
  • Measurement of glucose and glutamate-glutamine metabolism.
  • Assessment of GLUT3 mRNA and PFKp protein expression.
  • Pharmacological inhibition of PI3K-Akt-mTOR signaling pathway.

Main Results:

  • A significant increase in mitochondrial biogenesis, mass, morphology, and function was observed.
  • Upregulation of mitochondrial transcription factor A (TFAM) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) correlated with mitochondrial changes.
  • Increased glucose metabolism, uptake, GLUT3 mRNA, and PFKp protein expression occurred during differentiation.
  • Elevated glutamate-glutamine metabolism was detected.
  • PI3K-Akt-mTOR signaling was identified as a critical regulator of neuronal energy metabolism.

Conclusions:

  • Metabolic checkpoints involving mitochondrial biogenesis and glucose metabolism are essential for neuronal differentiation.
  • The PI3K-Akt-mTOR pathway plays a critical role in regulating energy metabolism during neuronal development.